DIA.MI
DiaSorin S.p.A. [DIA.MI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DIA.MI Stock Summary
Top 10 Correlated ETFs
DIA.MI
Top 10 Correlated Stocks
DIA.MI
In the News
DIA.MI Financial details
Company Rating
Buy
Market Cap
4.62B
Income
183.94M
Revenue
1.42B
Book val./share
-
Cash/share
-
Dividend
1.1
Dividend %
1.22%
Employees
3.18K
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
32.16
Forward P/E
-
PEG
-191.58
P/S
4.03
P/B
3.1
P/C
-
P/FCF
15.66
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
0.69
-
-
EPS (TTM)
4.1
EPS next Y
-
EPS next Q
-
EPS this Y
-28.54%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.48%
Revenue last 5Y
10.2%
Revenue Q/Q
111.71%
EPS Q/Q
170.21%
-
-
-
-
SMA20
-7.18%
SMA50
2.54%
SMA100
-0.86%
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
10%
ROC
-
Gross Margin
65%
Oper. Margin
23%
Profit Margin
13%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
81.24-106.9
52W High
-15.49%
52W Low
+10.59%
RSI
52.04
Rel Volume
1.07
Avg Volume
174.55K
Volume
187.11K
Perf Week
0.9%
Perf Month
-3.72%
Perf Quarter
9.24%
Perf Half Y
6.39%
-
-
-
-
Beta
0.15
-
-
Volatility
1.37%, 3.91%
Prev Close
-1.08%
Price
89.58
Change
0.22%
DIA.MI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 12.91 | 16.09 | 21.67 | 23.57 | 21.54 | |
| Net income per share | 3.21 | 4.53 | 5.44 | 4.17 | 2.98 | |
| Operating cash flow per share | 4.25 | 5.56 | 7.01 | 6.74 | 0 | |
| Free cash flow per share | 3.23 | 4.2 | 4.96 | 4.77 | 0 | |
| Cash per share | 3.69 | 6.21 | 6.79 | 7.16 | 0 | |
| Book value per share | 15.51 | 17.43 | 23.92 | 26.3 | 0 | |
| Tangible book value per share | 8.74 | 10.95 | -10.07 | -8.23 | 0 | |
| Share holders equity per share | 15.51 | 17.43 | 23.92 | 26.3 | 0 | |
| Interest debt per share | 0.61 | 0.69 | 24.81 | 24.02 | 0 | |
| Market cap | 6.31B | 9.31B | 9.56B | 7.53B | 4.97B | |
| Enterprise value | 6.19B | 9.01B | 10.56B | 8.64B | 0 | |
| P/E ratio | 35.93 | 37.58 | 30.76 | 31.26 | 31.25 | |
| Price to sales ratio | 8.94 | 10.57 | 7.73 | 5.53 | 4.33 | |
| POCF ratio | 27.14 | 30.58 | 23.87 | 19.34 | 0 | |
| PFCF ratio | 35.7 | 40.54 | 33.76 | 27.32 | 0 | |
| P/B Ratio | 7.44 | 9.76 | 7 | 4.96 | 0 | |
| PTB ratio | 7.44 | 9.76 | 7 | 4.96 | 0 | |
| EV to sales | 8.76 | 10.22 | 8.53 | 6.35 | 0 | |
| Enterprise value over EBITDA | 21.78 | 23 | 19.58 | 16.18 | 0 | |
| EV to operating cash flow | 26.58 | 29.58 | 26.35 | 22.19 | 0 | |
| EV to free cash flow | 34.97 | 39.21 | 37.26 | 31.35 | 0 | |
| Earnings yield | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Free cash flow yield | 0.03 | 0.02 | 0.03 | 0.04 | 0 | |
| Debt to equity | 0.03 | 0.04 | 1.02 | 0.89 | 0 | |
| Debt to assets | 0.03 | 0.03 | 0.43 | 0.4 | 0 | |
| Net debt to EBITDA | -0.45 | -0.78 | 1.84 | 2.08 | 0 | |
| Current ratio | 4.33 | 4.46 | 3.21 | 3.1 | 0 | |
| Interest coverage | 52.98 | 95.92 | 19.09 | 10.05 | 15.67 | |
| Income quality | 1.32 | 1.23 | 1.29 | 1.62 | 0 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Payout ratio | 0.28 | 0.21 | 0.18 | 0.24 | 0 | |
| Sales general and administrative to revenue | 0.1 | 0.07 | 0.08 | 0.08 | 0 | |
| Research and developement to revenue | 0.07 | 0.06 | 0.06 | 0.07 | 0.08 | |
| Intangibles to total assets | 0.35 | 0.29 | 0.6 | 0.59 | 0 | |
| Capex to operating cash flow | -0.24 | -0.25 | -0.29 | -0.29 | 0 | |
| Capex to revenue | -0.08 | -0.08 | -0.09 | -0.08 | 0 | |
| Capex to depreciation | -0.95 | -1.23 | -1.22 | -0.74 | 0 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Graham number | 33.48 | 42.14 | 54.13 | 49.69 | 0 | |
| ROIC | 0.2 | 0.24 | 0.12 | 0.09 | 0 | |
| Return on tangible assets | 0.25 | 0.28 | 0.24 | 0.17 | 0 | |
| Graham Net | 3.26 | 4.94 | -20.25 | -19.17 | 0 | |
| Working capital | 408.28M | 553.7M | 660.06M | 727.19M | 0 | |
| Tangible asset value | 478.34M | 599.58M | -575.43M | -475.31M | 0 | |
| Net current asset value | 315.83M | 423.79M | -904.92M | -814.12M | 0 | |
| Invested capital | 0.03 | 0.04 | 1.02 | 0.89 | 0 | |
| Average receivables | 145.74M | 153.59M | 196.47M | 256.43M | 0 | |
| Average payables | 56.51M | 60.61M | 75.13M | 94.49M | 0 | |
| Average inventory | 165.76M | 181.18M | 244.64M | 302.28M | 0 | |
| Days sales outstanding | 72.61 | 69.03 | 66.72 | 76.86 | 0 | |
| Days payables outstanding | 93.47 | 85.85 | 74.94 | 82.59 | 0 | |
| Days of inventory on hand | 287.01 | 250.72 | 263.48 | 242.93 | 0 | |
| Receivables turnover | 5.03 | 5.29 | 5.47 | 4.75 | 0 | |
| Payables turnover | 3.9 | 4.25 | 4.87 | 4.42 | 0 | |
| Inventory turnover | 1.27 | 1.46 | 1.39 | 1.5 | 0 | |
| ROE | 0.21 | 0.26 | 0.23 | 0.16 | 0 | |
| Capex per share | -1.02 | -1.37 | -2.05 | -1.97 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 6.52 | 5.41 | 5.13 | 5.07 | 0 | |
| Net income per share | 0.71 | 0.78 | 0.81 | 0.47 | 0 | |
| Operating cash flow per share | 1.53 | 0.77 | 1.87 | 1.5 | 0 | |
| Free cash flow per share | 0.45 | 0.77 | 1.02 | 1.5 | 0 | |
| Cash per share | 7.72 | 6.96 | 5.59 | 4.56 | 0 | |
| Book value per share | 28.39 | 28.52 | 26.75 | 29.15 | 0 | |
| Tangible book value per share | -8.88 | -2.4 | -14.4 | -2.74 | 0 | |
| Share holders equity per share | 28.39 | 28.52 | 26.75 | 29.15 | 0 | |
| Interest debt per share | 25.78 | 23.02 | 20.56 | 20.17 | 0 | |
| Market cap | 6.98B | 5.19B | 5.33B | 4.61B | 0 | |
| Enterprise value | 8.09B | 4.82B | 6.27B | 4.36B | 0 | |
| P/E ratio | 45.9 | 31.14 | 29.55 | 46.05 | 0 | |
| Price to sales ratio | 20 | 17.94 | 18.59 | 17.06 | 0 | |
| POCF ratio | 85.06 | 126.08 | 51.06 | 57.57 | 0 | |
| PFCF ratio | 292.59 | 126.08 | 93.15 | 57.57 | 0 | |
| P/B Ratio | 4.59 | 3.4 | 3.57 | 2.96 | 0 | |
| PTB ratio | 4.59 | 3.4 | 3.57 | 2.96 | 0 | |
| EV to sales | 23.19 | 16.65 | 21.87 | 16.16 | 0 | |
| Enterprise value over EBITDA | 87.51 | 74.07 | 97.7 | 75.21 | 0 | |
| EV to operating cash flow | 98.59 | 117.04 | 60.08 | 54.53 | 0 | |
| EV to free cash flow | 339.15 | 117.04 | 109.6 | 54.53 | 0 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Free cash flow yield | 0 | 0.01 | 0.01 | 0.02 | 0 | |
| Debt to equity | 0.89 | 0.8 | 0.76 | 0.69 | 0 | |
| Debt to assets | 0.4 | 0.4 | 0.5 | 0.37 | 0 | |
| Net debt to EBITDA | 12.01 | -5.72 | 14.67 | -4.19 | 0 | |
| Current ratio | 3.1 | 0 | 3.23 | 0 | 0 | |
| Interest coverage | 3.39 | 5.97 | 4.36 | 0 | 0 | |
| Income quality | 2.16 | 0.99 | 1.18 | 3.2 | 0 | |
| Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
| Payout ratio | 0.04 | 0 | 1.3 | 0 | 0 | |
| Sales general and administrative to revenue | 0.07 | 0.1 | 0.11 | 0.11 | 0 | |
| Research and developement to revenue | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | |
| Intangibles to total assets | 0.59 | 0.64 | 0.87 | 0.68 | 0 | |
| Capex to operating cash flow | -0.71 | 0 | -0.45 | 0 | 0 | |
| Capex to revenue | -0.17 | 0 | -0.16 | 0 | 0 | |
| Capex to depreciation | -0.82 | 0 | -0.73 | 0 | 0 | |
| Stock based compensation to revenue | 0.01 | 0 | 0.01 | 0 | 0 | |
| Graham number | 21.3 | 22.36 | 22.04 | 17.54 | 0 | |
| ROIC | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
| Return on tangible assets | 0.03 | 0.04 | 0.15 | 0.03 | 0 | |
| Graham Net | -20.68 | -15.86 | 6.01 | -15.61 | 0 | |
| Working capital | 727.19M | 797.1M | 629.89M | 634M | 0 | |
| Tangible asset value | -475.31M | -128.7M | 7.4M | -146M | 0 | |
| Net current asset value | -814.12M | -424.2M | 619.27M | -441M | 0 | |
| Invested capital | 0.89 | 0.8 | 0.76 | 0.69 | 0 | |
| Average receivables | 143.31M | 143.31M | 103.71M | 103.71M | 0 | |
| Average payables | 104.2M | 52.1M | 53.38M | 53.38M | 0 | |
| Average inventory | 306.5M | 153.25M | 161.26M | 161.26M | 0 | |
| Days sales outstanding | 73.95 | 0 | 65.09 | 0 | 0 | |
| Days payables outstanding | 78.93 | 0 | 96.09 | 0 | 0 | |
| Days of inventory on hand | 232.15 | 0 | 290.27 | 0 | 0 | |
| Receivables turnover | 1.22 | 0 | 1.38 | 0 | 0 | |
| Payables turnover | 1.14 | 0 | 0.94 | 0 | 0 | |
| Inventory turnover | 0.39 | 0 | 0.31 | 0 | 0 | |
| ROE | 0.03 | 0.03 | 0.03 | 0.02 | 0 | |
| Capex per share | -1.09 | 0 | -0.84 | 0 | 0 |
DIA.MI Frequently Asked Questions
What is DiaSorin S.p.A. stock symbol ?
DiaSorin S.p.A. is a IT stock , located in Saluggia of Vc and trading under the symbol DIA.MI
What is DiaSorin S.p.A. stock quote today ?
DiaSorin S.p.A. stock price is $89.58 today.
Is DiaSorin S.p.A. stock public?
Yes, DiaSorin S.p.A. is a publicly traded company.
Company Profile
- Volume Average 174.55K
- Market Capitalization 4.62B
- Employee 3.18K
- CEO Mr. Carlo Rosa
- Headquarters Saluggia,VC,IT
- IPO Date 2007-07-19
-
Website
https://diasoringroup.com 
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.
